Loading clinical trials...
Loading clinical trials...
Alterations in conventional coagulation tests in patients with cirrhosis and/or portal hypertension do not reliably predict bleeding risk, as hemostatic balance is complex and often compensated. Many ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT05899231 · Cirrhosis, Liver, Liver Transplant Surgery, and more
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT07429864 · HBV, HBV Coinfection, and more
NCT07343037 · Hepatic Insufficiency, Cirrhosis, Liver
Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli,
Roma
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions